Public trial registry of the CCC-Munich

Trial CC-486-AML-001

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CC-486-AML-001
World
Full title
:

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to compare efficacy and safety of Oral Azacitidine plus best supportive care versus best supportive care as Maintenance Therapy in subjects with Acute Myeloid Leukemia in complete remission  

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- C92.0 Akute myeloblastische Leukämie [AML]
Trial design
World
Phase
:
III
Status
World
Status
:
Recruitment finished
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo

Participants
Function Prename Surname Organization
World Responsible contact Katharina Götze 3. Med 3. Med Ismaninger Str. 22 81675 München Germany Magnifier